Works matching IS 21938210 AND DT 2023 AND VI 13 AND IP 12
Results: 22
Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 2929, doi. 10.1007/s13555-023-00995-z
- By:
- Publication type:
- Article
Real-Life Utility of Basophil Activation Test in the Diagnosis of Immediate Hypersensitivity Drug Reactions.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3229, doi. 10.1007/s13555-023-01069-w
- By:
- Publication type:
- Article
Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3209, doi. 10.1007/s13555-023-01063-2
- By:
- Publication type:
- Article
Comorbidity Burden and Treatment Patterns of Psoriasis in Vietnam: Real-World Data from the EXPAND Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3193, doi. 10.1007/s13555-023-01062-3
- By:
- Publication type:
- Article
Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3043, doi. 10.1007/s13555-023-01060-5
- By:
- Publication type:
- Article
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3165, doi. 10.1007/s13555-023-01059-y
- By:
- Publication type:
- Article
Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3121, doi. 10.1007/s13555-023-01057-0
- By:
- Publication type:
- Article
Dietary Factors and Hidradenitis Suppurativa.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3007, doi. 10.1007/s13555-023-01056-1
- By:
- Publication type:
- Article
The Benefits of a Multimechanistic Antiaging Skin Technology.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3111, doi. 10.1007/s13555-023-01055-2
- By:
- Publication type:
- Article
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3031, doi. 10.1007/s13555-023-01054-3
- By:
- Publication type:
- Article
The Diagnostic Workup, Screening, and Treatment Approaches for Patients with Delusional Infestation.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 2993, doi. 10.1007/s13555-023-01053-4
- By:
- Publication type:
- Article
A Mini Review of the Impact of Baseline Disease Severity on Clinical Outcomes: Should We Compare Atopic Dermatitis Clinical Trials?
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3019, doi. 10.1007/s13555-023-01052-5
- By:
- Publication type:
- Article
Management of Pediatric Psoriasis: A U.S. Survey Based on Visits from the National Ambulatory Medical Care Survey (NAMCS).
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3221, doi. 10.1007/s13555-023-01051-6
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3153, doi. 10.1007/s13555-023-01050-7
- By:
- Publication type:
- Article
Microneedling with a Novel, n-3-PUFA-Rich Formulation Accelerates Inflammation Resolution to Improve Skin Recovery Outcomes in Adults with Healthy Skin.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3057, doi. 10.1007/s13555-023-01049-0
- By:
- Publication type:
- Article
Emerging Medical Therapies in Rosacea: A Narrative Review.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 2933, doi. 10.1007/s13555-023-01048-1
- By:
- Publication type:
- Article
Efficacy of Avène Hydrotherapy on Chronic Pruritus in Patients with Plaque Psoriasis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3137, doi. 10.1007/s13555-023-01047-2
- By:
- Publication type:
- Article
Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 2951, doi. 10.1007/s13555-023-01044-5
- By:
- Publication type:
- Article
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3085, doi. 10.1007/s13555-023-01042-7
- By:
- Publication type:
- Article
Application and Comparison of Dermoscopy and Reflectance Confocal Microscopy in the Target Treatment of Genital Lichen Sclerosus: A Single-Arm Prospective Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3071, doi. 10.1007/s13555-023-01039-2
- By:
- Publication type:
- Article
Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3097, doi. 10.1007/s13555-023-01037-4
- By:
- Publication type:
- Article
Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3181, doi. 10.1007/s13555-023-01033-8
- By:
- Publication type:
- Article